Search

everythinglearnresearchcommunity

for

Search:↓

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

ONO-3403 effectively reduces mouse skin tumor growth without side effects.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

Tyrosine kinase inhibitors effectively treat cancers but often cause skin and other side effects.

Tofacitinib helped a patient regrow hair after 40 years of total hair loss.

Gefitinib can cause hair and eyebrow darkening.

JAK inhibitors can help regrow hair in alopecia areata but have potential long-term risks and require careful monitoring.

Baricitinib works better in adolescents than adults for treating severe alopecia areata.

Baricitinib helps regrow hair in teens with severe alopecia areata.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

AZD6244 treatment causes skin aging effects by depleting skin stem cells.

Selumetinib causes fewer and less severe skin issues in children than binimetinib.

Tyrosine kinase inhibitors for endocrine tumors often cause skin issues, requiring early management and treatment adjustments.

Tofacitinib significantly improved skin and hair conditions without side effects.

JAK inhibitors are safe and effective for treating moderate-to-severe alopecia areata.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

JAK inhibitors help regrow hair in alopecia areata, but their long-term safety is still unclear.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

Upadacitinib effectively treats severe alopecia areata and is safe.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.